Stopping Apixaban Without Tapering
Tapering is not required for routine discontinuation of apixaban (Eliquis). [1] Apixaban should only be stopped under the prescriber’s direction because interruption increases thromboembolic risk. [2]
Practical Discontinuation Approach
Apixaban discontinuation is typically managed as a brief interruption rather than a taper because direct oral anticoagulants have rapid offset. [1] Major perioperative guidance for factor Xa inhibitors uses planned holds based on procedure bleeding risk rather than gradual dose reduction. [3]
Perioperative Interruption (When Stopping Is Needed Temporarily)
For procedures with bleeding risk, apixaban is generally held for a defined interval before surgery. [3] Examples of guideline-consistent timing include holding factor Xa inhibitors for about 3 days preoperatively in many noncardiac surgery contexts. [3] Bridging anticoagulation with heparin is not recommended for most patients using DOACs because the time off anticoagulation is short. [4]
Stopping in Atrial Fibrillation or Venous Thromboembolism (When Discontinuation Is Permanent)
Permanent discontinuation should be coordinated with the clinician managing the indication because stopping increases stroke or systemic embolism risk in atrial fibrillation and recurrence risk in VTE. [2]
Situations Requiring Additional Clinician-Specific Management
Immediate and clinician-directed management is required for major bleeding or when urgent procedures occur because reversal or expedited strategies may be needed. [2]
Common Pitfall: Incorrect Assumption That Tapering Reduces Risk
Gradual tapering is not an evidence-based strategy for apixaban discontinuation in routine practice. [1] The evidence-based approach is interruption or stopping based on the clinical indication and bleeding/thrombotic risk rather than dose tapering. [3]
Key Clinical Decision Points
Discontinuation timing and any need for bridging depend on the reason for stopping (bleeding, procedure, drug interactions, or decision to end long-term anticoagulation). [3]
Safety Reminder
Apixaban should not be stopped without talking to the prescriber who prescribed it. [2]